- Home
- HLP vs CLDI Comparison
HLP vs CLDI Comparison
Compare HLP & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLP
- CLDI
- Stock Information
- Founded
- HLP 2021
- CLDI 2014
- Country
- HLP China
- CLDI United States
- Employees
- HLP N/A
- CLDI N/A
- Industry
- HLP Industrial Machinery/Components
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- HLP Industrials
- CLDI Health Care
- Exchange
- HLP Nasdaq
- CLDI Nasdaq
- Market Cap
- HLP 15.5M
- CLDI 18.1M
- IPO Year
- HLP 2023
- CLDI N/A
- Fundamental
- Price
- HLP $1.13
- CLDI $2.20
- Analyst Decision
- HLP
- CLDI Strong Buy
- Analyst Count
- HLP 0
- CLDI 3
- Target Price
- HLP N/A
- CLDI $16.67
- AVG Volume (30 Days)
- HLP 14.1K
- CLDI 3.3M
- Earning Date
- HLP 11-26-2024
- CLDI 11-12-2024
- Dividend Yield
- HLP N/A
- CLDI N/A
- EPS Growth
- HLP N/A
- CLDI N/A
- EPS
- HLP N/A
- CLDI N/A
- Revenue
- HLP $14,045,084.00
- CLDI N/A
- Revenue This Year
- HLP N/A
- CLDI N/A
- Revenue Next Year
- HLP N/A
- CLDI N/A
- P/E Ratio
- HLP N/A
- CLDI N/A
- Revenue Growth
- HLP N/A
- CLDI N/A
- 52 Week Low
- HLP $0.72
- CLDI $0.14
- 52 Week High
- HLP $5.54
- CLDI $3.89
- Technical
- Relative Strength Index (RSI)
- HLP 37.50
- CLDI 59.35
- Support Level
- HLP $1.10
- CLDI $2.00
- Resistance Level
- HLP $1.31
- CLDI $3.89
- Average True Range (ATR)
- HLP 0.09
- CLDI 0.40
- MACD
- HLP 0.00
- CLDI 0.12
- Stochastic Oscillator
- HLP 8.61
- CLDI 41.72
About HLP Hongli Group Inc.
Hongli Group Inc is a cold roll formed steel profile manufacturer in China. It customizes and manufactures cold roll formed steel profiles for machinery and equipment in a variety of sectors, including but not limited to mining and excavation, construction, agriculture and transportation.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical stage immuno-oncology company pioneering the development and commercialization of novel, potent and efficient stem cell-based platforms for delivery and potentiation of oncolytic viruses for the treatment of cancer.